首页 | 本学科首页   官方微博 | 高级检索  
     


Development of a heterologous radioimmunoassay for canine osteocalcin
Authors:S. P. Wang  K. T. Demarest  J. W. Gunnet  D. J. Baylink  K. -H. William Lau
Affiliation:(1) Department of Medicine and Biochemistry, Loma Linda University, 11201 Benton Street, 92357 Loma Linda, California, USA;(2) Department Mineral Metabolism Unit (151), Jerry L. Pettis Memorial Veterans' Medical Center, 11201 Benton Street, 92357 Loma Linda, California, USA;(3) R.W. Johnson Pharmaceutical Research Institute, 08869 Raritan, New Jersey, USA
Abstract:The aim of this study was to develop a routine and reliable radioimmunoassay (RIA) for dog osteocalcin. Two peaks of dog osteocalcin were purified to apparent homogeneity according to N-terminal sequence analysis. Amino acid composition analysis suggested that the second peak was intact dog osteocalcin whereas the first peak could be a truncated molecule. High titer (>1:5,000) anti-dog osteocalcin antisera were produced in rabbits. The antiserum recognized dog and rat osteocalcins but not that in serum of human, bovine, rabbit, mouse, guinea pig, or goat. A homologous RIA using anti-dog osteocalcin as the antibody and dog osteocalcin as the tracer and standard was developed. Taking advantages of the facts that (1) anti-dog osteocalcin crossreacted in parallel with rat osteocalcin and (2) purified rat osteocalcin is commercially available, we devised an approach that used rat osteocalcin as the tracer and standard, and anti-dog osteocalcin as the antibody to develop a heterologous RIA. This assay recognized dog serum osteocalcin and diluted in parallel with rat and dog osteocalcins. Quantitation was done using rat osteocalcin to construct standard curves, and results were expressed in ng/ml of rat osteocalcin-equivalent. The detection limit of the assay was 5 ng/ml rat osteocalcin-equivalent, and half-maximal displacement was seen at 30–40 ng/ml rat osteocalcin-equivalent. The inter-and intraassay variations were 16.1% and 8.5%, respectively. The assay accurately determined the amount of exogenously added dog osteocalcin in serum. The results quantitated with this RIA correlated well (r-0.975, n=86) with those obtained with the homologous RIA. Application of the heterologous assay to dogs of different age revealed that young dogs (3 months old) had 15-fold higher serum osteocalcin level than adult (>2 years old) dogs. In summary, we have (1) purified dog osteocalcin; (2) produced an antiserum against it; and (3) developed a heterologous RIA that could accurately measure dog osteocalcin, and could be used routinely to measure dog osteocalcin.This work was presented in part at the annual meeting of the American Society of Bone and Mineral Research in Minneapolis, September 1992.
Keywords:Osteocalcin  Radioimmunoassay  Bone formation  Biochemical marker  Dog
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号